Cyclin G1 plays an essential role in the development of human
carcinoma. Here, we characterized the clinical significance of
Cyclin G1 and investigated its role in cellular proliferation and apoptosis of
epithelial ovarian cancer (EOC). Western blot was used to evaluate the expression of
Cyclin G1 in nine fresh EOC tissues and three fresh normal ovarian tissues. Immunohistochemistry analysis was performed on
formalin-fixed
paraffin-embedded section of 119 cases of EOCs. Using cell counting kit (CCK)-8 and colony formation assays, we analyzed the effect of
Cyclin G1 in cellular proliferation of EOC. Besides, the immunofluorescence and flow cytometry analysis was performed to study the role of
Cyclin G1 in cellular apoptosis of EOC. We found
Cyclin G1 was up-regulated in EOC tissues compared with the normal ovary tissues.
Cyclin G1 expression in EOC was closely correlated with differentiation grade (P = 0.009) and malignant
tumor cells in
ascites (P = 0.009). The Kaplan-Meier curve showed that higher expression of
Cyclin G1 was associated with significantly shorter survival in EOC patients. Multivariate analysis suggested
Cyclin G1 expression was an independent prognostic factor for overall survival.
CCK-8 and colony formation assays revealed that depletion of
Cyclin G1 inhibited the proliferation and clone formation. Combined immunofluorescence and flow cytometry analysis showed that silencing of
Cyclin G1 with
shRNA could promote apoptosis of
ovarian cancer cells. Additionally, the result of immunoprecipitation test showed
Cyclin G1 interacted with CDK2 in EOC cells. In summary, our findings suggest that
Cyclin G1 may be involved in the prognosis of EOC patients and be a useful therapeutic target for EOC.